An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents

Peer Review reports

Original Submission
11 Jul 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
14 Apr 2014	Reviewed	Reviewer Report - Paolo Bossi
15 Apr 2014	Reviewed	Reviewer Report - Alexandre Bozec
Resubmission - Version 3
	Submitted	Manuscript version 3
14 May 2014	Reviewed	Reviewer Report - Paolo Bossi
19 May 2014	Reviewed	Reviewer Report - Alexandre Bozec
31 May 2014	Author responded	Author comments - julien PERON
Resubmission - Version 4
31 May 2014	Submitted	Manuscript version 4
11 Jun 2014	Reviewed	Reviewer Report - Paolo Bossi
2 Jul 2014	Author responded	Author comments - julien PERON
Resubmission - Version 5
2 Jul 2014	Submitted	Manuscript version 5
Publishing
4 Jul 2014	Editorially accepted
10 Jul 2014	Article published	10.1186/1471-2407-14-504

Back to article page